Author: GlobeNewswire

WALTHAM, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) — Invivyd, (Nasdaq: IVVD), formerly Adagio Therapeutics (Nasdaq: ADGI), a clinical-stage biopharmaceutical company…

WOBURN, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (“Biofrontera” or the “Company”) (NASDAQ: BFRI), announced today that they…

CALGARY, Alberta, Oct. 12, 2022 (GLOBE NEWSWIRE) — Biosenta Inc. (the “Company” or “Biosenta”) (CSE: ZRO) has signed a milestone…

First ever phase 3 program of psilocybin therapy globally scheduled to begin in 2022LONDON, Oct. 12, 2022 (GLOBE NEWSWIRE) —…

BOCA RATON, Fla., Oct. 11, 2022 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”),…

REYKJAVIK, Iceland, Oct. 11, 2022 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and…

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today…

VANCOUVER, British Columbia, Oct. 07, 2022 (GLOBE NEWSWIRE) — Agra Ventures Ltd. (“AGRA” or the “Company”) (CSE: AGRA) (OTC: AGFAF),…

HOUSTON and BURLINGTON, Ontario, Oct. 07, 2022 (GLOBE NEWSWIRE) — RadioMedix, Inc. (“RadioMedix” or “Company”), a clinical-stage biotechnology company announced…

CALGARY, Alberta, Oct. 07, 2022 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX…